Healthcare company-building profile
Columbia Lab-to-Market Accelerator Network
Columbia University (Columbia Technology Ventures)
AcceleratorUniversity acceleratorUniversityActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- University accelerator
- Organization
- Columbia University (Columbia Technology Ventures)
- Organization type
- University
- Location
- New York, New York
- Company stage served
- Not publicly documented
- Cohort or participation model
- Annual accelerator calls with milestone-based translational project funding
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Not publicly documented
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
Public description
About the program
The Lab-to-Market Accelerator Network is Columbia Technology Ventures' umbrella of translational accelerators that move faculty inventions toward licensing and startup formation, including biomedical and drug-discovery tracks such as the Irving Cancer Drug Discovery Program. CTV pairs the accelerators with the CTV Fellows and Columbia Startup Fellows programs and hosts Columbia ventures through Activate New York. Recent spinouts include ventures from Columbia bioengineering and chemistry labs.
What the program publicly emphasizes
Focus areas and features
Biomedical technologycancer drug discoverytherapeuticsmedical deviceshealth AI
- Category: University accelerator
- Program structure: Annual accelerator calls with milestone-based translational project funding
Publicly documented people and network
Program leadership and alumni
- Notable alumni named in public materials
- Nanovib; Redox Metals
Sources
External source links open in a new tab.